These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 29604986)

  • 1. HIV-associated neurocognitive disorder.
    Smail RC; Brew BJ
    Handb Clin Neurol; 2018; 152():75-97. PubMed ID: 29604986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathogenesis of human immunodeficiency virus infection.
    Sillman B; Woldstad C; Mcmillan J; Gendelman HE
    Handb Clin Neurol; 2018; 152():21-40. PubMed ID: 29604978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid immune markers and HIV-associated neurocognitive impairments: A systematic review.
    Williams ME; Stein DJ; Joska JA; Naudé PJW
    J Neuroimmunol; 2021 Sep; 358():577649. PubMed ID: 34280844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders.
    Rosenthal J; Tyor W
    J Neurovirol; 2019 Oct; 25(5):673-685. PubMed ID: 30868422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversies in HIV-associated neurocognitive disorders.
    Nightingale S; Winston A; Letendre S; Michael BD; McArthur JC; Khoo S; Solomon T
    Lancet Neurol; 2014 Nov; 13(11):1139-1151. PubMed ID: 25316020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications and limitations of inflammatory biomarkers for studies on neurocognitive impairment in HIV infection.
    Cassol E; Misra V; Morgello S; Gabuzda D
    J Neuroimmune Pharmacol; 2013 Dec; 8(5):1087-97. PubMed ID: 24259252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive Disorders in HIV-positive Patients.
    Padole PS; Padhiyar RN; Yadav DS; Chavan SA
    J Assoc Physicians India; 2023 Jun; 71(6):11-12. PubMed ID: 37355842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.
    Hong S; Banks WA
    Brain Behav Immun; 2015 Mar; 45():1-12. PubMed ID: 25449672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.
    Chan P; Brew BJ
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):317-24. PubMed ID: 24966139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.
    Kallianpur AR; Wang Q; Jia P; Hulgan T; Zhao Z; Letendre SL; Ellis RJ; Heaton RK; Franklin DR; Barnholtz-Sloan J; Collier AC; Marra CM; Clifford DB; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Grant I;
    J Infect Dis; 2016 Apr; 213(7):1065-73. PubMed ID: 26690344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury.
    Yuan NY; Kaul M
    J Neuroimmune Pharmacol; 2021 Mar; 16(1):90-112. PubMed ID: 31385157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication.
    Vassallo M; Fabre R; Durant J; Lebrun-Frenay C; Joly H; Ticchioni M; DeSalvador F; Harvey-Langton A; Dunais B; Laffon M; Cottalorda J; Dellamonica P; Pradier C
    J Neurovirol; 2017 Apr; 23(2):216-225. PubMed ID: 27815816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.
    Anderson AM; Lennox JL; Mulligan MM; Loring DW; Zetterberg H; Blennow K; Kessing C; Koneru R; Easley K; Tyor WR
    J Neurovirol; 2017 Feb; 23(1):106-112. PubMed ID: 27400930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological soft signs as a marker of cognitive impairment severity in people living with HIV.
    Toro P; Ceballos ME; Pesenti J; Inostroza M; Valenzuela D; Henríquez F; Forno G; Herold C; Schröder J; Calderón J
    Psychiatry Res; 2018 Aug; 266():138-142. PubMed ID: 29870954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-associated neurocognitive disorders (HAND).
    Elbirt D; Mahlab-Guri K; Bezalel-Rosenberg S; Gill H; Attali M; Asher I
    Isr Med Assoc J; 2015 Jan; 17(1):54-9. PubMed ID: 25739180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies.
    Ances BM; Clifford DB
    Curr Neurol Neurosci Rep; 2008 Nov; 8(6):455-61. PubMed ID: 18957181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment.
    Eggers C; Arendt G; Hahn K; Husstedt IW; Maschke M; Neuen-Jacob E; Obermann M; Rosenkranz T; Schielke E; Straube E;
    J Neurol; 2017 Aug; 264(8):1715-1727. PubMed ID: 28567537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive dysfunction in the highly active antiretroviral therapy era.
    Mothobi NZ; Brew BJ
    Curr Opin Infect Dis; 2012 Feb; 25(1):4-9. PubMed ID: 22156897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.
    Marin-Webb V; Jessen H; Kopp U; Jessen AB; Hahn K
    PLoS One; 2016; 11(12):e0168225. PubMed ID: 27992497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection.
    Kallianpur AR; Gittleman H; Letendre S; Ellis R; Barnholtz-Sloan JS; Bush WS; Heaton R; Samuels DC; Franklin DR; Rosario-Cookson D; Clifford DB; Collier AC; Gelman B; Marra CM; McArthur JC; McCutchan JA; Morgello S; Grant I; Simpson D; Connor JR; Hulgan T;
    Mol Neurobiol; 2019 May; 56(5):3808-3818. PubMed ID: 30209774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.